GemVax & KAEL Co Ltd
KOSDAQ:082270
GemVax & KAEL Co Ltd
Research & Development
GemVax & KAEL Co Ltd
Research & Development Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
G
|
GemVax & KAEL Co Ltd
KOSDAQ:082270
|
Research & Development
-₩21B
|
CAGR 3-Years
-27%
|
CAGR 5-Years
-40%
|
CAGR 10-Years
-22%
|
|
|
Hanmi Semiconductor Co Ltd
KRX:042700
|
Research & Development
-₩19.2B
|
CAGR 3-Years
2%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
-7%
|
|
|
E
|
EO Technics Co Ltd
KOSDAQ:039030
|
Research & Development
-₩865.7m
|
CAGR 3-Years
29%
|
CAGR 5-Years
6%
|
CAGR 10-Years
14%
|
|
|
W
|
Wonik IPS Co Ltd
KOSDAQ:240810
|
Research & Development
-₩160.2B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
N/A
|
|
|
H
|
HPSP Co Ltd
KOSDAQ:403870
|
Research & Development
-₩10B
|
CAGR 3-Years
-31%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
I
|
ISC Co Ltd
KOSDAQ:095340
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
GemVax & KAEL Co Ltd
Glance View
GemVax & KAEL Co., Ltd. engages in the production of chemical filters and gas scrubbers for semiconductors. The company is headquartered in Daejeon, Daejeon. The company went IPO on 2005-06-24. The firm and its subsidiaries are engaged in the three categories of businesses: pollution control business, which manufactures chemical air (CA) filters, gas scrubbers, resins, coating resins and other environmental equipments and systems; anticancer and anti-inflammation business, which engages in development of cancer vaccines for infectious diseases, such as acquired immune deficiency syndrome (AIDS) and anti-inflammations, and IT business which mainly produces liquid crystal display (LCD) modules. The firm distributes its products within domestic market and to overseas markets.
See Also
What is GemVax & KAEL Co Ltd's Research & Development?
Research & Development
-21B
KRW
Based on the financial report for Sep 30, 2025, GemVax & KAEL Co Ltd's Research & Development amounts to -21B KRW.
What is GemVax & KAEL Co Ltd's Research & Development growth rate?
Research & Development CAGR 10Y
-22%
Over the last year, the Research & Development growth was 37%. The average annual Research & Development growth rates for GemVax & KAEL Co Ltd have been -27% over the past three years , -40% over the past five years , and -22% over the past ten years .
